Drugs / darTregs
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02474199 | Jun 2016 → Dec 2019 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | darTregs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02474199 ↗ |
| Modality | Cell therapy | “A recipient's Tregs can be grown in the laboratory to increase their number.” NCT02474199 ↗ |
| Route | Intravenous | “infused intravenously (IV) over an approximate 20-30 minute interval” NCT02474199 ↗ |